Skip to main content

AlloVir, Inc. (NASDAQ: ALVR) Investor Securities Class Action Lawsuit 01/19/2024

  • If you purchased a significant amount of shares of AlloVir, Inc. (NASDAQ: ALVR) between March 22, 2022 and December 21, 2023, and / or if you purchased any NASDAQ: ALVR shares prior to March 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: March 19, 2024. NASDAQ: ALVR investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 19, 2024 - An investor in shares of AlloVir, Inc. (NASDAQ: ALVR) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by AlloVir, Inc. in connection with certain allegedly false and misleading statements made between March 22, 2022 and December 21, 2023. Waltham, MA based AlloVir, Inc. (NASDAQ: ALVR), a...

You must register (for free) or login to view the entire case.